IL209591A0 - Diazepan and piperazine derivatives modulators of chemokine receptors - Google Patents
Diazepan and piperazine derivatives modulators of chemokine receptorsInfo
- Publication number
- IL209591A0 IL209591A0 IL209591A IL20959110A IL209591A0 IL 209591 A0 IL209591 A0 IL 209591A0 IL 209591 A IL209591 A IL 209591A IL 20959110 A IL20959110 A IL 20959110A IL 209591 A0 IL209591 A0 IL 209591A0
- Authority
- IL
- Israel
- Prior art keywords
- diazepan
- chemokine receptors
- piperazine derivatives
- modulators
- derivatives modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08161278 | 2008-07-28 | ||
PCT/EP2009/059270 WO2010012619A1 (en) | 2008-07-28 | 2009-07-20 | Diazepan and piperazine derivatives modulators of chemokine receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL209591A0 true IL209591A0 (en) | 2011-01-31 |
Family
ID=41130181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL209591A IL209591A0 (en) | 2008-07-28 | 2010-11-25 | Diazepan and piperazine derivatives modulators of chemokine receptors |
Country Status (13)
Country | Link |
---|---|
US (1) | US8138175B2 (zh) |
EP (1) | EP2321285A1 (zh) |
JP (1) | JP5389917B2 (zh) |
KR (1) | KR101354421B1 (zh) |
CN (1) | CN102112451B (zh) |
AR (1) | AR072754A1 (zh) |
AU (1) | AU2009276090A1 (zh) |
BR (1) | BRPI0916574A2 (zh) |
CA (1) | CA2730770A1 (zh) |
IL (1) | IL209591A0 (zh) |
MX (1) | MX2011000755A (zh) |
TW (1) | TW201008921A (zh) |
WO (1) | WO2010012619A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8445674B2 (en) | 2009-10-21 | 2013-05-21 | Hoffmann-La Roche Inc | Heterocyclyl compounds |
EP2484674A1 (en) * | 2011-02-02 | 2012-08-08 | Rottapharm S.P.A. | Spiro aminic compounds with NK1 antagonist activity |
CN103613530B (zh) * | 2013-12-02 | 2015-08-19 | 江苏弘和药物研发有限公司 | 一种芴甲氧羰基-3-哌啶醇的合成方法 |
CN111423454B (zh) * | 2020-04-24 | 2021-06-22 | 苏州大学 | 哌嗪类化合物及其在制备趋化因子受体ccr2拮抗剂中的应用 |
CN112920079A (zh) * | 2021-01-29 | 2021-06-08 | 广西田园生化股份有限公司 | 一种酰胺化合物的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9929569D0 (en) | 1999-12-14 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
GB9929687D0 (en) | 1999-12-15 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
DE60114413T2 (de) * | 2000-05-25 | 2006-07-27 | F. Hoffmann-La Roche Ag | Substituierte 1-aminoalkyl-lactame und deren verwendung als muscarinrezeptor-antagonisten |
CZ20024199A3 (cs) * | 2000-05-25 | 2004-01-14 | F. Hoffmann-La Roche Ag | Substituované 1-aminoalkyllaktamy a jejich použití jako antagonisty muskarinového receptoru |
US6974869B2 (en) * | 2001-09-18 | 2005-12-13 | Bristol-Myers Squibb Pharma Company | Piperizinones as modulators of chemokine receptor activity |
EP1619193A4 (en) * | 2003-04-18 | 2010-08-11 | Ono Pharmaceutical Co | SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF |
US20070238723A1 (en) * | 2004-10-15 | 2007-10-11 | Goble Stephen D | Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
JP2006137718A (ja) * | 2004-11-12 | 2006-06-01 | Astellas Pharma Inc | インドール若しくはインダゾール誘導体 |
EP1846411A4 (en) * | 2005-01-25 | 2010-08-04 | Glaxo Group Ltd | ANTIBACTERIAL ACTIVE SUBSTANCES |
DE602007008222D1 (de) | 2006-04-20 | 2010-09-16 | Hoffmann La Roche | Diazepanderivate als modulatoren von chemokinrezeptoren |
JP2010510224A (ja) * | 2006-11-17 | 2010-04-02 | アボット・ラボラトリーズ | ケモカイン受容体拮抗薬としてのアミノピロリジン類 |
-
2009
- 2009-07-20 BR BRPI0916574A patent/BRPI0916574A2/pt not_active IP Right Cessation
- 2009-07-20 AU AU2009276090A patent/AU2009276090A1/en not_active Abandoned
- 2009-07-20 MX MX2011000755A patent/MX2011000755A/es active IP Right Grant
- 2009-07-20 WO PCT/EP2009/059270 patent/WO2010012619A1/en active Application Filing
- 2009-07-20 KR KR1020117002161A patent/KR101354421B1/ko not_active IP Right Cessation
- 2009-07-20 CA CA2730770A patent/CA2730770A1/en not_active Abandoned
- 2009-07-20 EP EP09780804A patent/EP2321285A1/en not_active Withdrawn
- 2009-07-20 JP JP2011520429A patent/JP5389917B2/ja not_active Expired - Fee Related
- 2009-07-20 CN CN200980129640.XA patent/CN102112451B/zh not_active Expired - Fee Related
- 2009-07-23 US US12/507,858 patent/US8138175B2/en not_active Expired - Fee Related
- 2009-07-27 TW TW098125263A patent/TW201008921A/zh unknown
- 2009-07-27 AR ARP090102845A patent/AR072754A1/es unknown
-
2010
- 2010-11-25 IL IL209591A patent/IL209591A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201008921A (en) | 2010-03-01 |
CN102112451A (zh) | 2011-06-29 |
BRPI0916574A2 (pt) | 2015-11-10 |
AU2009276090A1 (en) | 2010-02-04 |
EP2321285A1 (en) | 2011-05-18 |
JP5389917B2 (ja) | 2014-01-15 |
MX2011000755A (es) | 2011-02-24 |
AR072754A1 (es) | 2010-09-15 |
CA2730770A1 (en) | 2010-02-04 |
KR20110025228A (ko) | 2011-03-09 |
US20100022518A1 (en) | 2010-01-28 |
WO2010012619A1 (en) | 2010-02-04 |
KR101354421B1 (ko) | 2014-01-22 |
CN102112451B (zh) | 2014-01-22 |
JP2011529095A (ja) | 2011-12-01 |
US8138175B2 (en) | 2012-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL194556A0 (en) | Diazepan derivatives modulators of chemokine receptors | |
IL210769A0 (en) | Piperazine d3 and 5-ht2a receptor modulators | |
HK1217335A1 (zh) | 調節劑及其使用方法 | |
ZA201000354B (en) | Dual modulators of 5-HT2A and D3 receptors | |
IL210412A0 (en) | Heterocyclic derivatives and uses thereof | |
EP2344484A4 (en) | MODULATORS OF S1P RECEIVERS AND THEIR USE | |
IL213596A0 (en) | Heterocyclic compounds and methods of use | |
EP2264017A4 (en) | Heterocyclic derivative and its use | |
HK1157751A1 (zh) | 橋連雜環化合物及其使用方法 | |
SG10201400162QA (en) | Tgr5 modulators and methods of use thereof | |
EP2215073A4 (en) | SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS | |
HK1150274A1 (zh) | 稠合的雜環衍生物及其用途 | |
EP2480081A4 (en) | Bridged heterocyclic compounds and methods for their use | |
ECSP10010558A (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa | |
ZA201601457B (en) | Modulators of 5-ht receptors and methods of use thereof | |
IL210067A0 (en) | Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors | |
EP2166848A4 (en) | SPIROINDOLINES AS MODULATORS OF CHEMOKINE RECEPTORS | |
IL218795A0 (en) | Diazepam derivatives as modulators of chemokine receptors | |
EP2178371A4 (en) | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | |
IL209591A0 (en) | Diazepan and piperazine derivatives modulators of chemokine receptors | |
EP2314588A4 (en) | COMPOUNDS OF ESTROGENATED RECEPTOR MODULATORS AND THEIR USE | |
IL207649A0 (en) | Substituted (pyrazolylcarbonyl) imidazolidinones and their use | |
PL2237782T3 (pl) | Zastosowanie tetrahydropirymidyn | |
GB0703514D0 (en) | Use of riboflavin | |
EP2421862A4 (en) | OCTAHYDROBENZOISOCHINOLINE MODULATORS OF DOPAMINE RECEPTORS AND THEIR USE |